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The function and impact of EGF-like peptide signalling during ovulation and in vivo oocyte maturation 2 
(IVV) has been recently characterised, however little is currently known about the effect of oocyte in 3 
vitro maturation (IVM) on this pathway. The aim of this study was to examine expression and functional 4 
aspects of three EGF-like peptides (amphiregulin, epiregulin and betacellulin) and their common 5 
receptor (EGFR) in cumulus cells during mouse oocyte IVM compared to IVV. Cumulus-oocyte 6 
complexes (COCs) were collected from prepubertal mice either 46h post-eCG (IVM) or after eCG plus 7 
0.5-12 h post-hCG (IVV). Time course experiments showed mRNA expression of all three EGF-like 8 
peptides and amphiregulin protein in IVM media were significantly lower for the majority of FSH-9 
supplemented IVM compared with IVV. The supplementation of EGF during IVM yielded EGF-like 10 
peptide expression levels comparable to IVV and amphiregulin/epiregulin supplemented IVM. However, 11 
despite this, EGF activation of the COC EGFR remained significantly lower at 3h and 6h of IVM than in 12 
vivo, and levels were similar to those observed during FSH-supplemented IVM. The addition of 13 
exogenous epiregulin during IVM significantly increased blastocyst rates, and epiregulin and 14 
amphiregulin improved blastocyst quality, compared with FSH or EGF. In conclusion, findings from this 15 
study suggest that the widely used IVM additives, FSH and EGF, are inadequate propagators of the 16 
essential EGF-like peptide signalling cascade. By contrast, the use of epiregulin and/or amphiregulin 17 
during IVM leads to improved oocyte developmental competence and therefore may be preferable IVM 18 






Oocyte in vitro maturation (IVM) is a reproductive technique that involves the collection of immature 23 
oocytes from unstimulated or minimally stimulated ovaries that are then matured in vitro in medium 24 
containing low doses of gonadotropins, usually follicle stimulating hormone (FSH). The use of IVM in a 25 
clinical setting remains poor since, compared to IVF, IVM success rates (embryos and offspring 26 
generated per oocyte collected) are lower and miscarriage rates are higher (Banwell and Thompson 27 
2008; Buckett et al. 2008; Child et al. 2002). This is attributed to reduced developmental competence of 28 
oocytes after IVM (Gilchrist and Thompson 2007), however the molecular mechanisms underlying this 29 
remain unclear. In order to improve IVM outcomes, an understanding of the mechanisms that confer 30 
oocyte developmental competence in vivo and how they are affected by maturation in vitro is 31 
imperative. 32 
 33 
New insight into the mechanism by which luteinizing hormone (LH) induces resumption of oocyte 34 
maturation, cumulus cell matrix expansion and oocyte ovulation in the mammalian ovary have come to 35 
light within the last decade. Studies have demonstrated that epidermal growth factor (EGF)-like 36 
peptides are important propagators of the LH signal. LH induces fast and transient upregulation in 37 
expression of three members of the EGF growth factor family: amphiregulin (AREG); epiregulin 38 
(EREG); and betacellulin (BTC) in the mural granulosa cells and cumulus cells (CCs) of several animal 39 
species as well as human (Ashkenazi et al. 2005; Ben-Ami et al. 2006; Freimann et al. 2004; Motola et 40 
al. 2008; Park et al. 2004; Sekiguchi et al. 2004; Shimada et al. 2006; Zamah et al. 2010). The 41 
importance of EGF-like peptides in the propagation of the LH signal in vivo was revealed when mice 42 
null for Areg or Ereg exhibited compromised oocyte meiotic resumption, cumulus matrix expansion and 43 
ovulation; mice null for one EGF-like peptide generally only exhibit a mild phenotype, which is believed 44 
to be due to a compensatory mechanism by the other EGF-like peptides (Hsieh et al. 2007). LH 45 
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upregulates expression of EGF-like peptides by acting on mural granulosa cells to induce activation of 46 
the p38 mitogen-activated protein kinase (p38MAPK), which in turn leads to sequential upregulation of 47 
the three EGF-like peptides (Shimada et al. 2006). The EGF-like peptides are then shed from the cell 48 
surface by proteolytic cleavage and bind to the EGF receptor (EGFR; a member of the ERbB family of 49 
tyrosine kinases) on both mural granulosa and cumulus cells, in an autocrine and paracrine fashion, 50 
respectively (Conti et al. 2006; Shimada et al. 2006). BTC and EREG have also been shown to signal 51 
through another member of the ERbB family, ERbB4; however evidence suggests that this receptor 52 
does not play a significant role in mediating EGF-like peptide signalling in mural and cumulus granulosa 53 
cells (Zamah et al. 2010). Cumulus cells are not directly affected by LH as they express only minute 54 
levels of the LH receptor, and hence initially rely on paracrine EGF-like peptide stimulation from the 55 
mural granulosa cells before they can autonomously produce these peptides (Conti et al. 2012). Ligand 56 
binding in cumulus cells leads to EGFR phosphorylation, for which a key downstream effector is 57 
extracellular signal-regulated kinase 1/2 (ERK1/2) (also known as MAPK3/1) and it is clear that ERK1/2 58 
activity is essential for cumulus expansion, resumption of meiosis and ovulation (Downs and Chen 59 
2008; Fan et al. 2009; Hsieh et al. 2007; Shimada et al. 2006; Su et al. 2002). ERK1/2 activation in both 60 
granulosa subtypes also induces autonomous production of the EGF-like peptides by a prostaglandin 61 
E2 and p38MAPK dependent process (Downs 2010). 62 
 63 
Currently, most research and clinical IVM protocols supplement FSH and/or EGF into the culture 64 
medium for oocyte maturation (Banwell and Thompson 2008). FSH was shown to upregulate EGF-like 65 
peptide production by mural granulosa cells and cumulus cells during IVM (Downs and Chen 2008; 66 
Prochazka et al. 2011). A recent human study has shown that amphiregulin mRNA expression at the 67 
end of IVM is significantly lower than that seen after in vivo oocyte maturation (IVV) in cumulus cells 68 
(Guzman et al. 2012). We have also shown in a previous study, using global microarray analysis, that 69 
expression of the three EGF-like peptides at the end of maturation is significantly lower in IVM-derived 70 
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mouse cumulus cells relative to their IVV counterparts, and apart from haemoglobin α an β peptide 71 
sequences, genes for the three peptides were the most differentially expressed (Kind et al. 2012). 72 
Several studies have investigated the use of exogenous EGF-like peptides during IVM with findings that 73 
amphiregulin, epiregulin, and to a lesser extent betacellulin, effectively stimulate meiotic maturation and 74 
cumulus expansion in cumulus-oocyte complexes (COCs) (Park et al. 2004; Prochazka et al. 2011). 75 
Furthermore, amphiregulin induced mRNA expression of all three EGF-like peptides in COCs cultured 76 
in vitro (Shimada et al. 2006). Prochazka et al. investigated the effect of EGF-like peptides in IVM on 77 
porcine oocyte developmental competence in comparison with gonadotropins and found that IVM with 78 
amphiregulin and/or epiregulin improved blastocyst development in comparison with FSH, LH and eCG 79 
(Prochazka et al. 2011). 80 
 81 
The primary objective of this study was to examine the consequences of FSH- and EGF-supplemented 82 
IVM on functional EGF-like peptide signalling in a mouse model. The secondary objective of the study 83 





Comparison of in vitro versus in vivo derived cumulus cell EGF-like peptide and receptor mRNA 89 
expression  90 
Global microarray analysis from our previous study revealed that the relative number of transcripts for 91 
Areg, Ereg and Btc are greatly reduced in cumulus cells derived from IVM relative to those derived from 92 
IVV (Kind et al. 2012). Here we have used quantitative RT-PCR to validate these microarray results and 93 
further examine the expression profile of the EGF-like peptides and their receptors. The relative 94 
abundance of cumulus cell mRNA transcripts during IVM and IVV was measured over the time course 95 
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of oocyte maturation (0-12 h) (Fig. 1). Cumulus cell mRNA expression of the three EGF-like peptides 96 
was absent following 46 h of ovarian stimulation with eCG when oocytes are at the germinal vesicle 97 
stage. During oocyte maturation, expression of all three peptides was significantly lower for the majority 98 
of IVM compared with IVV. Areg and Ereg expression levels were substantially lower in IVM cumulus 99 
cells at 6 h, 9 h and 12 h (p<0.005), while Btc expression was lower at 9 h and 12 h (p<0.01), 100 
compared to cumulus cells during maturation in vivo. There was notable expression of all three EGF-101 
like peptides at just the 3 h time-point of IVM, at levels statistically comparable to IVV (p>0.05). IVV 102 
cumulus cell expression of the three peptides was relatively constant from 3 h to 12 h, with the 103 
exception of Ereg which increased 3.5-fold from 9 to 12 h (p<0.05). 104 
 105 
There was no difference in Egfr mRNA expression between IVM and IVV at any time point measured. It 106 
was interesting to note, however, that the expression of Egfr was significantly down-regulated after the 107 
initial addition of gonadotropins in both maturation scenarios. ErbB4 mRNA was not detectable until 9 h 108 
in both maturation scenarios, and even when detected at 9 h and 12 h, its expression was very low 109 
making statistical analysis impractical; thus ErbB4 mRNA expression was not measured in subsequent 110 
experiments. The lack of ErbB4 expression during the early stages of maturation in this study is 111 
consistent with reports in the literature suggesting that EGFR is the predominant receptor mediating 112 
EGF-like peptide signalling pathway in follicular mural and cumulus granulosa cells (Zamah et al. 2010). 113 
 114 
Comparison of IVM versus IVV derived COCs on AREG protein expression  115 
To further validate the gene expression profile of EGF-like peptides expression in FSH-driven IVM 116 
versus IVV cumulus cells, COC AREG protein was measured in both maturation scenarios over a time 117 
course using ELISA (Fig. 2). Consistent with the Areg mRNA expression profile, IVM COCs produced 118 
and secreted significantly higher concentrations (p0.03) of AREG protein than their IVV counterparts 119 
at 3-6 h of maturation. Moreover, AREG was significantly higher in media conditioned by IVV COC at 6-120 
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9 h and 9-12 h maturation (p<0.03) compared with IVM (Fig. 2B).  EREG was also measured by ELISA 121 
however levels were below the limit of detection of the assay in both IVM and IVV COCs and 122 
conditioned media.  123 
 124 
Effects of FSH,EGF and EGF-like peptides in vitro and hCG in vivo on EGF-like peptide and Egfr 125 
mRNA expression 126 
As oocytes are most commonly matured in vitro with FSH or alternatively with FSH+EGF, we examined 127 
the effects of these treatments on cumulus cell EGF-like peptide mRNA expression compared to IVV 128 
matured oocytes and IVM matured oocytes with EGF-like peptides (Fig. 3). Cumulus cells were 129 
collected 6 h post hCG (IVV) and from IVM COCs matured in the presence of either no treatment 130 
(control), FSH, EGF, AREG, EREG or BTC for 6 h. In the absence of any IVM treatment, no EGF-like 131 
peptides were detected in cumulus cells. FSH treatment of IVM COCs failed to stimulate expression of 132 
all three EGF-like peptides to the level of IVV COCs. By contrast, treatment of IVM COCs with EGF, 133 
AREG or EREG significantly (p<0.05) increased Areg, Ereg and Btc expression compared to FSH to 134 
levels that were not significantly different to IVV expression levels. BTC-stimulated expression of Areg 135 
and Ereg was significantly (p<0.05) lower than AREG-, EREG-, EGF- and IVV-stimulated expression. 136 
However, BTC still promoted significantly (p<0.05) higher expression levels of Areg and Btc than FSH 137 
(p<0.05). No significant differences were observed in Egfr expression between IVV cumulus cells and 138 
all IVM treatments; however expression was significantly up-regulated in the absence of any IVM 139 
treatment (control).  140 
 141 
Effects of FSH and EGF in vitro and hCG in vivo on activation of EGFR and ERK1/2 142 
Immunodetection was used to measure EGFR and ERK1/2 phosphorylation in IVM COCs at a number 143 
of time points following culture with FSH and/or EGF, or after IVV (Fig. 4). Both FSH- and/or EGF-144 
supplemented IVM COCs contained significantly (p≤0.022) lower levels of phosphorylated EGFR 145 
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(pEGFR) than IVV COCs at 3 h and 6 h of maturation. EGF elicited early phosphorylation of EGFR, 146 
where pEGFR was significantly (p≤0.033) higher at 0.5 h in the presence of EGF and EGF+FSH, 147 
compared with FSH or IVV. No significant differences in pEGFR were seen at 9 h and 12 h of 148 
maturation. Despite the decreased pEGFR during IVM at 3 h and 6 h, there were no significant 149 
differences in total ERK1/2 (tERK1/2) (data not shown) or phosphorylated ERK1/2 (pERK1/2) between 150 
any of the stimulated IVM treatment groups (FSH/EGF/FSH+EGF) and IVV at any time point. pERK1/2 151 
levels in unstimulated (control) COCs were significantly lower than all other treatment groups at 6 h, 152 
and at 9 h (with the exception of EGF), and at 12 h (with the exception of EGF and FSH+EGF).  153 
 154 
Effects of FSH, EGF, AREG and EREG on oocyte developmental competence 155 
Since mRNA expression of the EGF-like peptides was significantly lower in standard (FSH) IVM 156 
cumulus cells compared with their IVV counterparts, IVM COCs were cultured in the presence of 157 
exogenous FSH, EGF, AREG and/or EREG and embryo development was compared. Day 6 blastocyst 158 
rate was significantly higher for COCs matured with EREG (p<0.05), but not AREG or AREG+EREG, 159 
compared with those cultured with FSH or EGF (Table II). Furthermore, COCs cultured with EREG 160 
showed a trend (p=0.0589) for a higher hatching blastocyst rate compared with those cultured with 161 
FSH. There were no significant differences in cleavage rate, day 5 blastocyst and hatching blastocyst 162 
rates, and day 6 hatching blastocyst rates between any groups. Embryo quality was examined via 163 
quantification of the trophectoderm (TE) and inner cell mass (ICM) of day 6 blastocysts. Although there 164 
were no significant differences in TE and ICM cell numbers between treatment groups, the proportion of 165 
ICM cells per total blastocyst cells was significantly (p≤0.036) higher in the presence of EREG or 166 
AREG, compared with FSH and EGF (Table II).  Such a change if cell ratio is indicative of an 167 






This study aimed to examine the consequences of FSH- and EGF-supplemented IVM on EGF-like 172 
peptide signalling. Here we have shown that EGF-like peptides are deficient in cumulus cells 173 
undergoing standard FSH-stimulated IVM, and that, while the addition of EGF to an IVM system yields 174 
EGF-like peptide mRNA expression comparable to IVV levels, it does not improve EGFR or ERK1/2 175 
activation, or improve oocyte developmental competence above that of FSH. This study also examined 176 
the effect of amphiregulin and epiregulin supplementation during IVM on oocyte developmental 177 
competence, and our results have shown that epiregulin increases blastocyst formation and quality and 178 
thereby improves oocyte developmental competence.    179 
 180 
 181 
LH-induced EGF-like peptide signalling in mural granulosa and cumulus cells is a critical event that 182 
occurs in the pre-ovulatory follicles of mammalian species, thus far confirmed in rodent, pig, cow, horse, 183 
macaque, and human (Ashkenazi et al. 2005; Ben-Ami et al. 2006; Freimann et al. 2004; Motola et al. 184 
2008; Park et al. 2004; Sekiguchi et al. 2004; Shimada et al. 2006; Zamah et al. 2010). The autocrine 185 
and paracrine expression of EGF-like peptides in both these somatic cell types plays a fundamental 186 
role in oocyte maturation, cumulus matrix expansion and ovulation (Conti et al. 2012). LH exerts its 187 
effect to upregulate expression of EGF-like peptides by acting on mural granulosa cells only. Cumulus 188 
cells are not directly stimulated by LH as they do not possess LH receptors, and therefore initially rely 189 
on paracrine EGF-like peptide stimulation from the mural granulosa cells before they can autonomously 190 
produce these peptides (Conti et al. 2006). Hence, one of the earliest signals the COC receives to 191 
resume meiosis and prepare for embryonic development, is from EGF-like peptides produced by mural 192 
granulosa cells. 193 
 194 
Evidence in the literature exists showing that initial activation of the EGF network by LH is quickly 195 
amplified and maintained during at least the first half of oocyte maturation (Ben-Ami et al. 2006; Motola 196 
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et al. 2008; Panigone et al. 2008; Shimada et al. 2006). The current study is the first to directly 197 
characterise and compare the cumulus cell EGF network throughout in vivo versus in vitro maturation. 198 
FSH is a universal hormonal additive in IVM. Here we show that, although FSH induces mRNA 199 
upregulation of the three EGF-like peptides in cumulus cells at the earliest stages of IVM, there is a 200 
sharp and significant decline in expression during the remainder of IVM. In contrast, EGF-like peptide 201 
mRNA expression by hCG during IVV is amplified and maintained over time. Furthermore, cumulus cell 202 
mRNA expression of all three EGF-like peptides and amphiregulin protein expression are significantly 203 
lower during the majority of FSH-supplemented IVM than during IVV. It is therefore not surprising that 204 
the level of activated EGFR during IVM is also significantly lower at 3 h and 6 h, compared to IVV.  205 
Mural granulosa cells are the major epithelial component of the pre-ovulatory follicle and are the source 206 
of a significant proportion of the EGF-like peptides produced and secreted in the follicle in response to 207 
LH (Eppig 1994; Park et al. 2004; Sekiguchi et al. 2004). The deficiency in EGF-like peptide expression 208 
and EGFR activation in FSH-supplemented IVM cumulus cells may be due to the absence of mural 209 
granulosa cells, which would otherwise secrete and expose cumulus cells to large amounts of EGF-like 210 
peptides, leading to their auto-amplification of this signalling network. Hence, it is possible that a major 211 
contributing factor to the poor developmental competence of oocytes derived from standard FSH-driven 212 
IVM systems is the continuous exposure of COCs to sub-optimal concentrations of one or all three 213 
EGF-like peptides throughout oocyte maturation. This idea is supported by our findings which showed 214 
that; (i) EGFR phosphorylation at the early stages of maturation is significantly lower in COCs treated 215 
with FSH during IVM than their IVV counterparts; and (ii) the exposure of IVM COCs to a high 216 
concentration of epiregulin significantly increases blastocyst rate and, epiregulin and/or amphiregulin 217 
improve blastocyst quality, compared with FSH. Amphiregulin and/or epiregulin supplementation during 218 
IVM has also been shown by others to induce higher developmental competence in porcine oocytes 219 
compared with FSH or LH (Prochazka et al. 2011).  220 
  221 
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EGF is rarely used in clinical IVM and is occasionally used in non-human research and veterinary IVM 222 
systems, usually in combination with FSH (Banwell and Thompson 2008). EGF induces oocyte meiotic 223 
resumption, cumulus expansion, and improves developmental competence in comparison with 224 
spontaneous oocyte maturation in several animal species (Rieger et al. 1998). Like FSH, EGF elicits 225 
cumulus expansion and oocyte meiotic resumption through activation of ERK1/2 (Conti et al. 2006; De 226 
La Fuente et al. 1999; Su et al. 2002); although unlike FSH, it does this by directly binding to and 227 
phosphorylating EGFR (Massague and Pandiella 1993). Here, we directly compared the effects of EGF 228 
and FSH during IVM, and hCG during IVV, on EGF-like peptide mRNA expression and EGFR 229 
signalling. Unlike FSH, EGF exposure during IVM stimulated cumulus cell mRNA expression of all three 230 
EGF-like peptides to levels comparable to IVV and amphiregulin- and epiregulin-supplemented IVM. 231 
Despite its ability to restore EGF-like peptide expression levels to those seen in vivo, EGF did not elicit 232 
an improvement in oocyte developmental competence over FSH. This may be attributed to its inability 233 
to maintain sufficient EGFR phosphorylation throughout IVM (Fig. 4); pEGFR levels were significantly 234 
higher in COCs during EGF-supplemented IVM than IVV after 30 minutes of maturation but were then 235 
lower at 3 and 6 hours of maturation, with levels similar to those of FSH matured IVM COCs. Perhaps 236 
unexpectedly, there were no detectable differences in ERK1/2 phosphorylation between EGF matured 237 
IVM COCs and their IVV counterparts, despite the difference in EGFR activity. This may be due to the 238 
phosphorylation of ERK1/2 via other signalling cascades since inhibition of EGFR activity only inhibits 239 
~50% of ERK1/2 phosphorylation in preovulatory follicles (Panigone et al. 2008). Alternatively, the lack 240 
of a difference in ERK1/2 phosphorylation, coupled with the improved developmental competence 241 
induced by amphiregulin and epiregulin, may suggest that EGF and the EGF-like peptides differentially 242 
regulate other EGFR activated pathways. EGFR ligands have distinct binding specificities and affinities, 243 
and depending on ligand interaction, EGFR activation can initiate several signal transduction pathways, 244 
predominantly the MAPK, AKT and JNK pathways (Oda et al. 2005). Further analysis of alternative 245 
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EGFR activated pathways may elucidate a mechanism by which EGF and the EGF-like peptides 246 
differentially regulate EGFR signalling.  247 
 248 
When the effects of the three EGF-like peptides, FSH and EGF during IVM on EGF-like peptide mRNA 249 
expression were examined, EGF, amphiregulin and epiregulin were found to induce comparable 250 
expression levels. Betacellulin, however, appears to be a less potent stimulator of EGF-like peptide 251 
signalling since it induces significantly lower Areg and Ereg expression than EGF, amphiregulin or 252 
epiregulin. This is likely the reason betacellulin is a poorer stimulator of oocyte meiotic resumption (Park 253 
et al. 2004). 254 
 255 
We compared the effects of FSH, EGF, amphiregulin and epiregulin during IVM on oocyte 256 
developmental competence and found epiregulin to increase day 6 blastocyst yield, and epiregulin or 257 
amphiregulin to improve blastocyst quality, over FSH and EGF. It is curious that EGF, epiregulin and 258 
amphiregulin yield differences in oocyte developmental competence despite acting through the same 259 
receptor, EGFR. As previously mentioned, EGFR ligands exhibit significant differences in intrinsic 260 
activity and can produce distinct biological outcomes (Wilson et al. 2009; Wilson et al. 2012), and this 261 
may explain, at least in part, the differences in developmental competence observed. For example, 262 
Wilson et al. (2012) have shown that amphiregulin possesses greater intrinsic activity than EGF, and 263 
that EGF competitively antagonises amphiregulin in human myeloid and breast cells. Different EGFR 264 
ligands also phosphorylate the receptor on distinct sets of tyrosine residues which likely alter EGFR 265 
signalling (Wilson et al. 2009). For instance, EGF elicits strong phosphorylation of EGFR Tyr 1045, 266 
whereas amphiregulin does not (Gilmore et al. 2008). Wilson et al. (2009) hypothesised that differential 267 
Tyr 1045 phosphorylation by different ligands leads to differences in the duration of the EGFR signal, 268 
with data suggesting that the duration of EGF-induced EGFR signalling is shorter than that of 269 




Although it has yet to be investigated, it has been suggested that amphiregulin and epiregulin 272 
accumulate together, and hence may have additive or synergistic effects on maturation in vivo (Conti et 273 
al. 2006). We investigated oocyte developmental competence outcomes when IVM COCs were 274 
matured with both epiregulin and amphiregulin and saw no synergistic or additive effects; rather, the 275 
positive effect of epiregulin on blastocyst yield was lost when amphiregulin was also present. Although 276 
we did not see an additive or synergistic effect, we cannot exclude the possibility of such effects at 277 
other concentrations of amphiregulin and epiregulin. 278 
 279 
In conclusion, findings from this study suggest that the common IVM additives, FSH and EGF, are 280 
inadequate propagators of the essential EGF-like peptide signalling cascade that occurs in cumulus 281 
cells in vivo. We have shown that FSH does not promote sufficient expression of EGF-like peptides 282 
when compared to levels in vivo. Furthermore, both FSH and EGF do not maintain adequate activation 283 
of the EGFR. The current study indicates that EGF-like peptides, rather than FSH or EGF, should be 284 
added to IVM systems as they were shown by us and others to improve embryo development.  Such an 285 
approach may represent a more physiological form of IVM as amphiregulin, epiregulin and betacellulin 286 
are naturally induced in the somatic cells of the follicle to induce cumulus expansion, oocyte maturation 287 
and ovulation.  288 
 289 
MATERIALS AND METHODS 290 
Unless otherwise specified, all chemicals were obtained from Sigma Aldrich (St Louis, USA). 291 
 292 
COC collection 293 
Mice were maintained in accordance with the Australian Code of Practice for Care and Use of Animals 294 
for Scientific Purposes and with the approval of the Adelaide University Animal Ethics Committee. 295 
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129/SV female mice were used for all experiments. COCs were collected from 21- to 28-day old mice, 296 
46 h after intraperitoneal injection of 5 IU of equine chorionic gonadotropin (eCG; Folligon, Intervet, 297 
Boxmeer, Holland) to stimulate follicular growth. Human chorionic gonadotropin (hCG, 5 IU; Organon, 298 
Sydney, Australia) was administered 46 h post-eCG for IVV experiments to induce oocyte maturation in 299 
vivo. COCs were isolated from preovulatory follicles using a 27-gauge needle and collected using 300 
flame-pulled borosilicate Pasteur pipettes in HEPES buffered αMEM (Gibco, Invitrogen, Carlsbad, USA) 301 
supplemented with 3 mg/mL bovine serum albumin (BSA).  302 
 303 
Oocyte in vitro maturation 304 
COCs were cultured in bicarbonate buffered αMEM (Gibco, Life Technologies, NY, USA) supplemented 305 
with 3 mg/mL BSA (ICPbio, Glenfield, New Zealand) and either: recombinant human FSH (100 mIU/mL; 306 
Puregon, Organon, USA), recombinant human EGF (10 ng/mL; R&D Systems, Minneapolis, USA), 307 
recombinant mouse AREG (50 ng/mL; R&D Systems), recombinant mouse EREG (50 ng/mL; R&D 308 
Systems), or recombinant mouse BTC (50 ng/mL; R&D Systems) at 37ºC and 5% CO2 in air. Doses of 309 
EGF family growth factors were based on previous studies using EGF (De La Fuente et al. 1999; Li et 310 
al. 2008) and EGF-like peptides (Downs and Chen 2008). 311 
  312 
RNA Isolation 313 
Following the indicated periods of in vivo or in vitro maturation, cumulus cells were separated from 314 
COCs by mechanical shearing using a P200 pipette and washed with PBS. Total RNA was extracted 315 
using the RNeasy Micro Kit (Qiagen, Germantown, USA) according to the manufacturer’s instructions. 316 
DNA that may have been co-purified was removed by addition of DNase (0.34 Kunitz units/µL supplied 317 
with kit). RNA was eluted in 14 µL of RNAse-free water and stored at -80ºC. The final RNA 318 
concentrations were determined by absorbance using a NanoDrop ND-1000 spectrophotometer 319 





An equal amount of total RNA from each sample was reverse transcribed using random hexamers (Life 323 
Technologies (Invitrogen) Mulgrave, Australia) and Superscript III reverse transcriptase (Invitrogen).  324 
Primers (10 pmol/reaction; Table I) and cDNA were added to 20 µL total reaction volume with SYBR 325 
Green (Applied Biosystems, Mulgrave, Australia). PCRs were then performed using a Corbett Rotor-326 
Gene 6000 (Qiagen). A seven point serial dilution standard curve was produced for each transcript from 327 
cDNA generated from mural granulosa cells. The relative gene expression values were calculated using 328 
the standard curve method and presented relative to a calibrator and normalised to the geometric mean 329 
of two housekeeping genes (Mrpl19 and Ppia).  To validate primer pairs, amplicons generated from 330 
mouse cumulus cell cDNA were run on 2% agarose gels and primer pairs were considered valid when 331 
a single product of the correct size was observed and primer efficiency was above 95%. 332 
 333 
ELISA 334 
AREG and EREG protein levels in COC extract and conditioned media were quantified using a 335 
commercially available mouse enzyme-linked immunosorbent assay kits (ELISA; R&D Systems, 336 
Minneapolis, USA) according to the manufacturer’s instructions. IVM COCs were cultured in vitro as 337 
described above in the presence of 100 mIU/mL FSH and 3 mg/mL BSA for 3, 6 or 9 h and then 338 
transferred into 100 µL culture media without FSH and cultured for a further 3 h. IVV COCs (50 per 339 
treatment) were collected at 3, 6 or 9 h post-hCG and cultured in 100 µL culture media without  FSH for 340 
3 h. The media and COCs were then collected separately and snap frozen in liquid nitrogen and stored 341 
at -800C. For the ELISA assay, COC samples were resuspended in 40 µL RIPA buffer containing 342 
protease inhibitors and freeze-thawed 4X in liquid nitrogen to lyse, and 50 µL of the kit’s reagent diluent 343 
containing protease inhibitors was added. Eighty microlitres of media or COC lysate were then 344 




EGFR and ERK1/2 Immunodetection 347 
Following the indicated periods of in vivo or in vitro maturation,  whole COCs were collected as 348 
described above and suspended in RIPA buffer (10 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 % Triton X-349 
100) containing phosphatase (Roche, Penzberg, Germany) and protease inhibitor cocktails, snap 350 
frozen in liquid nitrogen and stored at -80ºC. Samples were mixed with loading buffer containing 100 351 
mM dithiothreitol, heated at 1000C for 5 mins, and loaded onto a 7.5% SDS–polyacrylamide gel for 352 
electrophoresis. Proteins were transferred to Hybond-ECL membranes (GE Healthcare, Waukesha, 353 
USA). Membranes were then blocked with 2% blocking reagent (supplied in an ECL Advance kit; GE 354 
Healthcare) diluted in Tris-buffered saline containing 0.1% (v/v) Tween 20. Each membrane was cut in 355 
half horizontally and the upper half was incubated with the primary antibody anti-phospho-EGFR 356 
(pEGFR; Cell Signalling Technology, Beverley, USA, cat. no. 3777) diluted 1:1000, and the lower half 357 
was incubated with anti-phospho-ERK1/2 (pERK1/2; Sigma, cat. no. M8159) diluted 1:10,000 at 4°C 358 
overnight, followed by incubation with goat anti-rabbit IgG peroxidase-conjugated (diluted 1:200,000, 359 
Santa Cruz Biotechnology Inc, Santa Cruz, USA, cat. no. SC-2004) and donkey anti-mouse 360 
peroxidase-conjugated (diluted 1:400,000, Santa Cruz, cat. no. SC-2314) secondary antibodies, 361 
respectively. Binding was detected using the ECL Advance kit and exposure to Hyperfilm (GE 362 
Healthcare). The lower half membrane was then stripped using an acidic glycine stripping buffer (1% 363 
SDS, 25mM glycine, pH 2.0) and was incubated with anti-ERK1/2 (tERK1/2, Sigma, cat. no. M5670) 364 
diluted 1:10,000 at 4°C overnight, followed by incubation with goat anti-rabbit IgG peroxidase-365 
conjugated (diluted 1:400,000). This membrane was then stripped again and incubated with anti-β-Actin 366 
peroxidise conjugated antibody (diluted 1:20 million, Sigma, cat. no. A3854). Band intensities were 367 
measured using Image J software (NIH; Bethesda, USA). Band intensities for pEGFR, pERK1/2 and 368 
tERK1/2 were normalised to β-Actin band intensities and standardised relative to post-hCG values 369 
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(except at 3 h maturation where they were standardised to FSH&EGF values). Data is represented as 370 
the mean of at least three replicate experiments.  371 
 372 
Oocyte Developmental Competence 373 
To examine the effects of EGF-like peptides on oocyte developmental competence, COCs underwent 374 
IVM with various treatments, followed by IVF and in vitro embryo development to day 6. Immature 375 
COCs were collected from preovulatory follicles 46 h post-eCG into HEPES buffered αMEM. IVM was 376 
performed in bicarbonate buffered αMEM supplemented with 3 mg/ml BSA, 1 mg/ml fetuin and FSH or 377 
EGF peptides (as described above). Following 17 h of IVM, COCs were placed in Research VitroFert 378 
fertilization media (Cook Medical, William A. Cook Australia Pty Ltd., QLD, Australia, cat. no. K-RVFE-379 
50) with capacitated CBA x C57BL6 F1 epididymal  sperm for 4 h at 37ºC at 6% CO2, 5% O2 and 380 
balance of nitrogen. COCs were then transferred into Research VitroWash media (Cook Medical, cat. 381 
no. K-RVWA-50) and cumulus cells were removed by mechanical shearing with a P200 pipette. 382 
Presumptive zygotes were then washed and incubated in Research VitroCleave media (Cook Medical, 383 
cat. no. K-RVCL-50) at 37ºC with 6% CO2, 5% O2 and balance of nitrogen. Embryo development was 384 
assessed at days 2, 5 and 6 post-insemination using the scoring system reported by Gardner et al. 385 
(Gardner et al. 2004).  386 
 387 
Day 6 blastocyst trophectoderm (TE) and inner cell mass (ICM) cell numbers were quantified by 388 
differential staining using a published protocol (Hardy et al. 1989). Briefly, blastocysts were incubated in 389 
0.5% pronase at 37°C to remove the zona pellucida. Blastocysts were then placed in protein-free wash 390 
medium and placed in 10% 2,4,6-trinitrobenzene sulfonic acid for 10 mins at 4°C. They were then 391 
incubated with anti-2,4-8 dinitrophenol (1:10) for 10 mins at 37°C, followed by complement (1:1; 2 μg/ml 392 
propidium iodine:guinea pig serum) for a further 10 mins. Blastocysts were then incubated in 25 μg/ml 393 
Hoechst 33342 (bisbenzimide) in ethanol at 4°C overnight, and were then washed in 100% ethanol and 394 
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transferred into 5 µl drops of 100% glycerol on microscope slides and covered with a cover slip. Stains 395 
were visualised using an epifluorescent microscope excitation 340-380 nm, emission 440-480 nm). The 396 
ICM cells (stained blue) and TE cells (stained pink), of the embryo were counted. 397 
 398 
Statistical Analyses 399 
Statistical analyses were conducted using SigmaPlot 11.0 software. For PCR and Western blot data, 400 
statistical significance was assessed by ANOVA followed by Tukey’s multiple-comparison post-hoc 401 
tests to identify individual differences between means. Where data were not normally distributed, 402 
statistical significance was assessed by non-parametric Kruskal-Wallis one-way ANOVA by ranks. T-403 
tests were used to analyse ELISA data. All values are presented with their corresponding standard 404 
error of the mean (SEM). For embryo culture, statistical significance was assessed using Chi-Squared 405 
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Table I: Sequences of PCR primers used for RT-qPCR  525 
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Table II: Embryo development of IVM oocytes cultured in medium supplemented with FSH, EGF and 529 
EGF-like peptides 530 
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FIGURE LEGENDS 534 
 535 
Figure 1: Effect of maturation in vitro (IVM) compared to in vivo (IVV) on cumulus cell EGF-like 536 
peptide and receptor mRNA expression. Cumulus cells were harvested from IVM cumulus-oocyte 537 
complexes cultured with FSH (grey bars) and from IVV cumulus-oocyte complexes matured in vivo with 538 
hCG (black bars). mRNA expression was measured using quantitative RT-PCR and normalized to the 539 
geometric mean of the Mrpl19  and Ppia. Bars not sharing a common letter are significantly different; 540 
IVMa-d, IVVx-z (p ≤ 0.05). (*) indicate a significant difference (p ≤0.05). (#) indicates below limit of 541 
detection. Data is from 3 replicate experiments. 542 
 543 
Figure 2: Effect of maturation in vitro (IVM) compared to in vivo (IVV) on amphiregulin 544 
production. IVM cumulus-oocyte complexes were cultured in vitro with FSH and IVV cumulus-oocyte 545 
complexes were matured with hCG. Both cumulus-oocyte complex types were collected after 3 h, 6 h or 546 
9 h of maturation and placed in 100 µL bicarbonate buffered medium with 3 mg/ml BSA and cultured in 547 
vitro for a further 3 h. Amphiregulin (AREG) protein was measured in the cumulus-oocyte complexes 548 
(A) and their conditioned media (B) by ELISA and quantified using the standard curve method. (*) 549 
indicate a significant difference (p<0.03). (#) indicates below limit of detection. Data is from 4 replicate 550 
experiments. 551 
 552 
Figure 3: Effects of FSH, EGF and EGF-like peptides in vitro and hCG in vivo on cumulus cell 553 
EGF-like peptide and Egfr mRNA expression. Cumulus cells were harvested at 6 h from IVM 554 
cumulus-oocyte complexes cultured in the absence (control) or presence of FSH, EGF, AREG, EREG 555 
or BTC, or from IVV cumulus-oocyte complexes matured with hCG for 6. Bars not sharing a common 556 




Figure 4: Immunodetection of cumulus-oocyte complex EGFR and ERK1/2 phosphorylation in 559 
response to FSH and EGF in vitro and hCG in vivo. Cumulus-oocyte complexes were cultured via 560 
IVM in the absence (control) or presence of FSH, EGF or FSH+EGF, or matured via IVV with hCG for 561 
0.5 h, 3 h, 6 h, 9 h, or 12 h.  pEGFR and pERK1/2 levels were measured using Western blots. For each 562 
time point, a representative blot of at least 3 replicate experiments is shown and the quantified 563 
densitometric values below it. Densitometric measurements of pEGFR were normalised to β-actin and 564 
pERK1/2 were normalised to tERK1/2 in each individual blot. The blot bands shown are in order of the 565 
following treatments: p-hCG, control, FSH, EGF and FSH+EGF, respectively, and are representatives 566 
of pEGFR and pERK1/2. pEGFR, phosphorylated EGFR; pERK1/2, phosphorylated ERK1/2; tERK1/2, 567 
total ERK1/2.  568 
 569 
